与前列腺癌进展相关的单核酸多态:系统性审查
Daniel Felipe Mendivelso González1, Santiago Andrés Sánchez Villalobos1, Andrea Estefanía Ramos1
1Cancer Biology Research Group, Instituto Nacional de Cancerología, Bogotá, Colombia.
Cancer investigation
|December 6, 2023
概括
单核酸多态 (SNPs) 显示为前列腺癌 (PCa) 进展的生物标志物具有前景. 这次审查发现了许多与较高或较低风险相关的SNP,有助于PCa管理.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 前列腺癌 (PCa) 需要改进的生物标志物来准确分类和临床管理.
- 目前用于预测PCa进展的方法需要改进.
- 识别新的进展标志物对于患者的治疗结果至关重要.
研究的目的:
- 系统地审查单核酸多态 (SNP) 与前列腺癌进展之间的关联.
- 评估SNP作为PCa中的预测生物标志物的潜力.
- 综合有关影响PCa进展的遗传变异的证据.
主要方法:
- 2007-2022年主要科学数据库中的出版物的系统审查.
- 纳入标准:调整后的显著关联,≥24个月的随访,急性前列腺切除术患者,生化复发 (BCR) 数据.
- 分析了27篇精选的文章,报告了39个基因中的73个SNP.
主要成果:
- 在七个功能组中,在39个基因中发现了73个单核酸多态 (SNP).
- 50个SNP与PCa进展风险增加有显著的相关性.
- 23个SNP与PCa进展风险降低有关,以及四个显著的单元型.
结论:
- 单核酸多态 (SNP) 是前列腺癌进展的潜在生物标志物.
- 已识别的SNP可能在PCa的发展和进展中具有功能性作用.
- 需要进一步的研究来验证这些发现,特别是在不同的人群中,因为大多数变异是在有限的队列中确定的.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


